.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
. Ed(S): Kim, Hae Won; Greenburg, A.Gerson
€ 199.30
FREE Delivery in Ireland
Description for Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
Hardback. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes Editor(s): Kim, Hae Won; Greenburg, A.Gerson. Num Pages: 746 pages, 53 black & white illustrations, 77 colour illustrations, biography. BIC Classification: MBGR; MJF; PSB; TGM. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 41. Weight in Grams: 1316.
Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will provide readers a comprehensive review of topics involved in the HBOC development. It focusses on current products and clinical applications as well as on emerging technologies and future prospects.
Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will provide readers a comprehensive review of topics involved in the HBOC development. It focusses on current products and clinical applications as well as on emerging technologies and future prospects.
Product Details
Format
Hardback
Publication date
2013
Publisher
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Germany
Number of pages
746
Condition
New
Number of Pages
746
Place of Publication
Berlin, Germany
ISBN
9783642407161
SKU
V9783642407161
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics